| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid manufacturers
- (Rac)-AZD 6482
-
- $297.00
-
2026-05-11
- CAS:663620-70-0
- Purity:
- Supply Ability: 10g
- (Rac)-AZD 6482
-
- $297.00
-
2025-07-17
- CAS:663620-70-0
- Purity:
- Supply Ability: 10g
|
| | 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid Basic information |
| Product Name: | 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid | | Synonyms: | 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid;2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid;2-(1-(7-Methyl-2-Morpholino-4-oxo-4H-pyrido[1,2-a]pyriMidin-9-yl)ethylaMino)benzoic acid;(Rac)-AZD 6482;(Rac)-KIN-193;Benzoic acid, 2-[[1-[7-methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]-;(Rac)AZD 6482,(Rac) AZD 6482 | | CAS: | 663620-70-0 | | MF: | C22H24N4O4 | | MW: | 408.45 | | EINECS: | | | Product Categories: | | | Mol File: | 663620-70-0.mol | ![2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid Structure](CAS/GIF/663620-70-0.gif) |
| | 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid Chemical Properties |
| Boiling point | 635.5±65.0 °C(Predicted) | | density | 1.36 | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 3.90±0.50(Predicted) | | form | Solid | | color | White to light yellow |
| | 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid Usage And Synthesis |
| Uses | (Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC50 of 0.69 nM. | | References | [1] Ni J, et al. Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent. Cancer Discov. 2012 May;2(5):425-33. DOI:10.1158/2159-8290.CD-12-0003 |
| | 2-[[1-[7-Methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid Preparation Products And Raw materials |
|